ad image

Asher Biotherapeutics

1 / 1
Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility
CDMO - Small Biotech

Cis-Targeted Immunotherapies Need Large CDMO Expertise But Also Flexibility

Julie Trulson, Ph.D.

PAO-02-24-CL-07Feb 15, 2024
Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies
Tech Transfer

Transparent Communication Supports Tech Transfers Of Cis-targeted Immunotherapies

Julie Trulson, Ph.D.

PAO-02-24-CL-06Feb 15, 2024
1 / 1